Active	Status	Sponsor type	Region	Phase	Filter
4 Active 1 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   - « May » « 2025 » M T W T F S S 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1   Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ahmed, Faisal
CORE-008, NCT06567743: Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC	Recruiting	2	200	US	Cretostimogene Grenadenorepvec, CG0070	CG Oncology, Inc.	High-Risk Non-Muscle-Invasive Bladder Cancer	03/27	12/27
NCT04575376: Clinical Audit on Evaluation of Patient With Syncope at Asssiut University Children Hospital	Not yet recruiting	N/A	30	NA		Assiut University	Syncope	10/23	10/23
XLHRegistry, NCT03193476: Registry for Patients With X-Linked Hypophosphatemia	Recruiting	N/A	1343	Europe, RoW		Kyowa Kirin Pharmaceutical Development Ltd, Iqvia Pty Ltd	X-Linked Hypophosphatemia	02/29	07/29
Nowfar, Sepehr
CORE-008, NCT06567743: Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC	Recruiting	2	200	US	Cretostimogene Grenadenorepvec, CG0070	CG Oncology, Inc.	High-Risk Non-Muscle-Invasive Bladder Cancer	03/27	12/27

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Ahmed, Faisal
CORE-008, NCT06567743: Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC	Recruiting	2	200	US	Cretostimogene Grenadenorepvec, CG0070	CG Oncology, Inc.	High-Risk Non-Muscle-Invasive Bladder Cancer	03/27	12/27
NCT04575376: Clinical Audit on Evaluation of Patient With Syncope at Asssiut University Children Hospital	Not yet recruiting	N/A	30	NA		Assiut University	Syncope	10/23	10/23
XLHRegistry, NCT03193476: Registry for Patients With X-Linked Hypophosphatemia	Recruiting	N/A	1343	Europe, RoW		Kyowa Kirin Pharmaceutical Development Ltd, Iqvia Pty Ltd	X-Linked Hypophosphatemia	02/29	07/29
Nowfar, Sepehr
CORE-008, NCT06567743: Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC	Recruiting	2	200	US	Cretostimogene Grenadenorepvec, CG0070	CG Oncology, Inc.	High-Risk Non-Muscle-Invasive Bladder Cancer	03/27	12/27